{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T01:57:33Z","timestamp":1764813453533,"version":"3.46.0"},"reference-count":56,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BTT"],"DOI":"10.2147\/btt.s555169","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T01:55:12Z","timestamp":1764813312000},"page":"713-727","source":"Crossref","is-referenced-by-count":0,"title":["Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review"],"prefix":"10.2147","volume":"Volume 19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-7310","authenticated-orcid":true,"given":"Giorgio","family":"Galoppini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Garaffoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lotesoriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Nogarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Bortoluzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7654-8222","authenticated-orcid":true,"given":"Ettore","family":"Silvagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/acr.22513","volume":"67","author":"Baillet","year":"2015","journal-title":"Arthritis Care Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1586\/ecp.11.33","volume":"4","author":"Zhang","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.5414\/CP201904","volume":"51","author":"Zhang","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/annrheumdis-2013-203523","volume":"73","author":"Burmester","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/acr.22110","volume":"66","author":"Ogata","year":"2014","journal-title":"Arthritis Care Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/annrheumdis-2018-eular.2886","volume":"77","author":"Lauper","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1093\/rheumatology\/keac190","volume":"61","author":"Zhao","year":"2022","journal-title":"Rheumatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/03009742.2021.2003033","volume":"51","author":"Carrara","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/keae279","volume":"64","author":"Tian","year":"2025","journal-title":"Rheumatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fphar.2025.1565909","author":"Silvagni","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2500896","DOI":"10.1183\/13993003.02533-2024","author":"Antoniou","year":"2025","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jama.2016.13512","volume":"316","author":"Gottenberg","year":"2016","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"152249","DOI":"10.1016\/j.semarthrit.2023.152249","volume":"62","author":"Sparks","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/rheumatology\/keae334","volume":"64","author":"Miyazaki","year":"2025","journal-title":"Rheumatology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/ard-2022-223357","volume":"82","author":"Sepriano","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref17","first-page":"310","volume":"36","author":"Generali","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"152563","DOI":"10.1016\/j.semarthrit.2024.152563","volume":"69","author":"Pugliesi","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-immunol-101220-023458","volume":"40","author":"Kishimoto","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/ijms23031716","volume":"23","author":"Gusev","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1016\/S2665-9913(21)00112-0","volume":"3","author":"Saadoun","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326(6):499\u2013518. doi: 10.1001\/jama.2021.11330","DOI":"10.1001\/jama.2021.11330"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/rheumatology\/keaa653","volume":"60","author":"Gupta","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/RHU.0000000000001862","volume":"28","author":"C\u00e1ceres","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.55563\/clinexprheumatol\/1sjgyr","volume":"40","author":"Garaffoni","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheumat"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/pds.4582","volume":"27","author":"Rasmussen","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/1744666X.2019.1559050","volume":"15","author":"Buzatu","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"ref29","unstructured":"Adverse event | European medicines agency (EMA). Available from: https:\/\/www.ema.europa.eu\/en\/glossary-terms\/adverse-event. Accessed March 30, 2025."},{"key":"ref30","unstructured":"R: the R project for statistical computing. 2024. Available from: https:\/\/www.r-project.org\/. Accessed January 5, 2025."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref32","unstructured":"Study quality assessment tools | NHLBI, NIH. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools. Accessed January 20, 2023"},{"key":"ref33","unstructured":"Zotero | your personal research assistant. Available from: https:\/\/www.zotero.org\/. Accessed January 7, 2025."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5937\/afmnai38-31264","volume":"38","author":"Stojanovi\u0107","year":"2021","journal-title":"Acta Fac Medicae Naissensis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40744-018-0138-y","volume":"6","author":"Darloy","year":"2019","journal-title":"Rheumatol Ther"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"A115","DOI":"10.1136\/ejhpharm-2022-eahp.240","volume":"29","author":"Rodr\u00edguez de Francisco","year":"2022","journal-title":"Eur J Hosp Pharm"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.3346\/jkms.2022.37.e138","volume":"37","author":"Ahn","year":"2022","journal-title":"J Korean Med Sci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"744","DOI":"10.55563\/clinexprheumatol\/lxfy2v","volume":"41","author":"Daood","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105347","volume":"89","author":"Larid","year":"2022","journal-title":"Joint Bone Spine"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3109\/14397595.2015.1129692","volume":"26","author":"Iwamoto","year":"2016","journal-title":"Mod Rheumatol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1080\/14397595.2017.1416760","volume":"28","author":"Atsumi","year":"2018","journal-title":"Mod Rheumatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s10067-017-3587-8","volume":"36","author":"Desplats","year":"2017","journal-title":"Clin Rheumatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13075-016-1151-6","volume":"18","author":"Nikiphorou","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030499","volume":"12","author":"Maranini","year":"2022","journal-title":"J Pers Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3899\/jrheum.141042","volume":"42","author":"Reggia","year":"2015","journal-title":"J Rheumatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e021447","DOI":"10.1136\/bmjopen-2017-021447","volume":"8","author":"Silvagni","year":"2018","journal-title":"BMJ Open"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/PPA.S55156","volume":"8","author":"Huynh","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/cpt.2999","volume":"114","author":"den Broeder","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijid.2023.01.041","volume":"129","author":"Swets","year":"2023","journal-title":"Int J Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1517\/14740338.2015.998198","volume":"14","author":"McLaughlin","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref51","unstructured":"Baraliakos X. Comparative evaluation of adverse events associated with subcutaneous infliximab (CT-P13 SC) and intravenous infliximab: a real-world analysis of post-marketing surveillance data. ACR Meeting Abstracts. Available from: https:\/\/acrabstracts.org\/abstract\/comparative-evaluation-of-adverse-events-associated-with-subcutaneous-infliximab-ct-p13-sc-and-intravenous-infliximab-a-real-world-analysis-of-post-marketing-surveillance-data\/. Accessed April 3, 2025."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jbspin.2009.03.008","volume":"76","author":"Pham","year":"2009","journal-title":"Joint Bone Spine"},{"key":"ref53","first-page":"167","volume":"30","author":"Bruce","year":"2003","journal-title":"J Rheumatol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1093\/rheumatology\/keac261","volume":"61","author":"Silvagni","year":"2022","journal-title":"Rheumatology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1016\/S2665-9913(20)30175-2","volume":"2","author":"Yeoh","year":"2020","journal-title":"Lancet Rheumatol"}],"container-title":["Biologics: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/109565","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/109565","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T01:55:14Z","timestamp":1764813314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/switch-from-intravenous-to-subcutaneous-formulation-of-tocilizumab-in--peer-reviewed-fulltext-article-BTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"URL":"https:\/\/doi.org\/10.2147\/btt.s555169","relation":{},"ISSN":["1177-5491"],"issn-type":[{"value":"1177-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}